Current status and perspectives of hematopoietic cell transplantation in patients with paroxysmal nocturnal hemoglobinuria
BackgroundParoxysmal nocturnal hemoglobinuria (PNH) is a rare complement-driven acquired hemolytic anemia with specific presentations of hemoglobinuria, abdominal pain, fatigue, and thrombosis.ObjectiveTo review the current therapeutic strategies for PNH, including anti-complement therapy and alloge...
Saved in:
Main Authors: | Marek Ussowicz, Dawid Przystupski, Patrycja Mensah-Glanowska, Agnieszka Piekarska |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1521484/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Eculizumab treatment for Chinese patients with hemolytic paroxysmal nocturnal hemoglobinuria (PNH): efficacy and safety – a single-center study
by: Leyu Wang, et al.
Published: (2025-12-01) -
A 2-decade survival from a double hemolytic disease: A case of paroxysmal nocturnal hemoglobinuria with hemoglobinopathy
by: Aria Namiq Chaqmachi, et al.
Published: (2024-12-01) -
A method for selecting P antigen-negative red cell units for patients with paroxysmal cold hemoglobinuria
by: Geethika Sajeewani Manchanayake
Published: (2024-01-01) -
Clinical utility of hematological parameters in aplastic anemia
by: Lizhong Zhang, et al.
Published: (2025-01-01) -
Risk factors and clinical outcomes of cytomegalovirus infection following haploidentical hematopoietic stem cell transplantation in patients with aplastic anemia: a single-center retrospective study
by: Jia Feng, et al.
Published: (2025-01-01)